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The incubation of isolated hepatoeytes with the inhibitor of protein moan ADP-ribosylation, m-iodobenzyl8uanidine (MIBO), resulted in an 
increase in the dze or the mitochondrial Ca'~ pooh without alteration of the non.mJtochondrial Ca:* storg(~}, This inereaa; was abolished when 
the eytosolie free Ca:* concentration ([Ca"']3 was buffered by prior Ioadin8 of the cells with fluo 3, Elevatin~ [Ca'~+]~ by releasing the endoplasmi¢ 
A role for protein ADP-ribosylation in the intrac¢llular regulation ofmitochoadrial Ca:" homeostasis i  ~ugsested, 
m-lodobenzylguanidine; Mitoel~ondrla; C -'* efflux; Hepatocyte; ADP.ribosylation; 2,5.Di.(tert.butyl)-1,4-hydroquinone 
1. INTRODUCTION 
The electrogenic uptake of Ca 2+ into mitoehondria s 
¢coumefD~mnceh 'qy an dt-~gxron~tart~ ~'ifhux s vstem'~nm 
tfunctions independently ot"the membrane.ootential (l'or
recent reviews, see rel's. 1-3), In tissues uch as the heart 
and bra'm, a ~a z~ ~'lqa ~exe~r~er  ~s ~ae .vre6om'taam 
Ca 2+ efl]ux pathway, whereas in the liver, a Na+-inde- 
pendent pathway involving a Ca~-*/H * antiporter is the 
major Ca'-* ell'tax route, Lehninger and associates [4] 
proposed that Ca -~+ transport in liver mitochondria is
regulated by the redox st~ate of the mitochondrial pyri- 
dine nucleotides, uch that Ca 2+ release occurs upon the 
oxidation of the nucleotides. Similarly, the prooxidant- 
induced Ca -'~ release from mitoehondria inv¢!ves the 
oxidation of mitochondrial pyridine nueleotides [5,6] 
rather than a reversal of the uniporter or inner mem- 
brane damage [3,6-8]. 
Previous work from Riehter's [9] and this laboratory 
[10] has shown that pyridine nucleotide oxidation iz not 
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Abbreviations: [Ca-"]~, eytosoli¢ free Ca'-* concentration; MIBG, m- 
iodobenzylguanidine; FCCP. earbonyl cyanide 4.(triflaorom- 
etlaoxy)phenylhydrazone; tBaHQ, 2,5.di(tert-butyl)-l,4-hydroqui- 
none; ar~eaazo 111, 2,2'-[l,8-dihydroxy-3,6-disulfo-2,7-nalahthalene- 
bi~(azo)]dibenzenearsonic acid; titan 3, i.(2.amino-5.(2,7-dichloro- 
6.hydt'oxy.3-oxy-9-o.-xaatlle:lyl}-phenozy)-2-(2-amhlo-5-methylphe- 
no,~y}ethan~-N,N,N',N'-tetraaeetie cid: AM, a~toxymethyl ester; 
MPPL I-methyl.4-pheaylpyridine. 
sufficient o activate the Ca -~+ efflux pathway but re- 
quires the further hydrolysis of the oxidized pyridine 
nueleotide~ to nicotinamide and ADP-ribose. The latter 
the.orooxtdant-mduced Ca- re, ease ~rom m'ltoc'laondlr'la 
is regulated by protein moan ADP-ribosylation [11]. 
cent findings that m-iodobenzylguanidine (MIBG), a 
high affinhy compeiitive inhibixor of protein moan 
ADP-ribosylation [12], inhibits the prooxidant-indaeed 
Ca :+ release from rat liver mitochondria without afl~t- 
ing the aniport Ca'-* uptake system or pyr!dine nueleo- 
tide oxidation and hydrolysis [13]. 
In addition to preventing the prooxidant-mediated 
release of Ca:+ from mitochondria, MIBG also inhibits 
the spontaneous Ca:+ efliux [13]. Thi~ suggests a physi- 
ological role for protein ADP-ribo~ylation i  the regula- 
tion of the mitochondrial Ca -~* efflux pathway. How- 
ever, it is not known whether this spontaneous Ca"* 
efflux pathway found in isolated mitoehondria is also 
operative in an intact cell system and whether there it 
is also regulated by protein ADP-ribosylation. Hence. 
this study was aimed at investigating the role of protein 
ADP-ribosylation in the control of the mitochondrial 
Ca-'* efflux pathway in intact hepatoeytes. 
2. MATERIALS AND METHODS 
2.1. Cl'emicals 
Arsenazo Ill (98% pure), fura 2-AM and finn 3-AM were purchased 
from Sigma Chemical Co. (St. Louis, MO, USA). FCCP was obtained 
from Aldrich Chemic',tl Co. (Steinheim, FRO) and tBuHQ was pur- 
c ased from EOA-Ch,mi¢ (Steinheim, FRG). The Ca"" ionophore, 
A23187, was purgha~e,;t from Calloioehem (La Jolht. CA, USA), Coi- 
laBenase (grade il) and bovine serum albumit, were pttrcha~d IYom 
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Boehringer (Mannheim, FRG). MIBG sulplio~,¢ (purity ~.95%) wa.~ a 
generous ~ift from Dr L.A. Silk.eta, The Netherlands Cancer Institute, 
Amsterdam. All other chemicals were of the hi~,hest purity t~rade 
commerc!a!l), available. 
2.2. Hepatoeyte isolation atut klcubatiott 
Hepatoeytes were isolated from male Wistar ats ( 170-210 8,fed ad 
libitum) as described previously [14]. Between 90-95% of the freahly 
isolated hepatoeytes routinely excluded Trypan blue. Preineubation 
,'rod incubation conditions were as reported in [I 5], before xposing 
the hepatocytes (10 ~ eell~'ml inKrebs-Henseleit buffer, pH 7.4, ~up- 
plemented with 12.5 mM HEPES) to the eompound~ of intcrent. Con- 
trols received the appropriate vdaicle additio,ls; the vehicles were 
deionized water for MlllG and dimethyl sulfoxide for fura 2-AM, 
flue 3.AM and tBuHQ. 
2.3. E~TJerhnental deslgrl 
The measurement of he rniiochoadrial Ca ~'* pool in ilttaet hepato- 
eyte~ was estinaated asthe FCCP-relea~able Ca-'* pool after separation 
of the l~epatoeytes l¥om the incubation mint are by cent rifusation and 
t'esuspension f the cells in Ca:*- and Ms-~'-l'ree Iqanks' ~olution. 
[15,16]. Under these conditions the treatment of hcputocyte,s whh 
mitoehondrial uncouplers did not mobilize the endoplamfic reticular 
Ca :+ pool [17]. The cytosolie Ca :+ bufferin8 capacity of h~patocytes 
was increased by loading the cell-~ with the Ca"" el~elator l]uo 3 [18]. 
The cells were incubated with 15 ,(~M flue 3-AM lbr 15 rain using 
conditions previously de~c,'ib~d [19]. [Ca"']~ and Ca `'+ entry aeros~ th~ 
pla~rna membrane were measured fluorimetricall)' with fura 2, as 
reported in[19,20]. Cytotoxieit), was monitored b>, a chan~e in[Ca-"]~, 
the appearance of cell surf~t¢~ bleb~ a,~d the loss ~f the ability of th,' 
ceils to exclude Trypan blue. 
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Fig. i. MIBO.stin~ulates a cont'ent,'ation.dependeat incre.'tse in the 
content of the mitochondrial Ca "~* pool. Isolated hepatoeytes were 
treated with the indicated concentrations oF MIBG for 60 lain, before 
measuring the size of tl~e mitochondrial Ca-" pool as described in
section 2. Each paint represents he mean +_. S.E. or ilaree to six 
independe,n experiments. 
2.4. Statistical analysis 
All data are presented a,~ mea~ z S.E. of three to seven separate 
experimcntn. Duncan's multlple ranse test ',;as perlbrmed to deter- 
mine the ~ignificanee of differences amen8 individual ~roup means. 
The sisnil]canee l vel chosen for all statistical nalyse~ as P<0.05, 
The stlttistieal naly~c5 were carried out with the SPSS/PC ~ statistical 
paekaBe. 
3. RESULTS AND DISCUSSION 
The exposure of isolated hepatoeytes to MIBG for 60 
rain resulted in a concmtration-dependent increase in 
the size of the mitoehotadria! Ca ~" pool (Fig. 1), The 
threshold ¢oneenlration of  MIBG to produce a detecta- 
ble change in mitoehondrial Ca -~÷ content was 10/aM 
MIBG, and half-maximal and maximal accun,ulation 
of  Ca -'+ occurred with ttpproxirnately 100/aM and 250 
/AM MIBG, respectively. With 250~M MIBG, the con- 
tent of the mitochondrial Ca ~-÷ pool was incre~sed to 
1.20 nmol Ca:*/10 ~ cells ~s compared with 0.29 nmol 
Ca2+/10 ° control cells. No significant change in Ca 2~ 
content was detected in the other (Caa+-ionophore-re- 
leasable) cellular compartments (0,55 _ 0.06 and 0.52 
_+ 0,08 nmol Ca~+/106 cells with 100 #M and 250/aM 
MIBG, respectively, vs. 0.61 _+ 0.06 nmol Ca-~+/10 ~ cells 
in control cells). The changes in the magnitude of the 
mitochondrial Ca z+ pool occurred in the absence of any 
signs of toxicity to the hepatocytes. However, the expo. 
sure of hepatocytes to I mM MIBG resulted in exten- 
sive plasma membrane blebbing and alter 2 h produced 
a 86% dccreane in cell viability. This eytotoxicity wa`s 
probably due to ATP depletion resulting from the inhi° 
bitten of site 1 of the respiratory chain by MIBG [21]. 
The time course of  Ca "~+ accumulation in the mito- 
ehondrial pool by 100 ,aM MIBG is shown ia Fig. 2, 
The mitochondrial pool in MIBG-treated cells rose rap- 
idly to a maximal concentration of 0.92 nmol Ca2*/10 °
cells by 100 rain vs. 0.26 nmol Ca-~÷/10 c' cells for con- 
trois, Again, no change was found in the ionophore- 
releasable Ca -~" stores (data not shown). The size of the 
mitoehondrial Ca -~+ pool in the control cells remained 
unchanged for the first two hours. Subsequently, a small 
elevation occurred, probobly as a result of  a slowly 
developing net accumulation of extracellular Ca 2÷ by 
the cells. 
These results uggest hat the inhibition of  the .sponta- 
neous Ca -~÷ release from isolated mitochondria by 
M1BG [13] abe takes place in intact cells. Thu~, our 
findings are compatible with Richter's hypothesis [11] 
that protein mono ADP-ribosylation is a physiological 
regulatory mechanism of mitochondriai Ca 2+ homeo- 
stasis. Additionally, it appears that even under restin,g 
condition.s, there is substantial Ca ~-+ cycling occurring 
between the cytosol and the mitochondria. Although 
the affinity of the uniporter for Ca 2+ ia generally re- 
garded as being low [1], our time-course xperiments 
indicate that Ca '+ enters the mitochondria t a consider- 
able rate. It i` s possible that physiological regulators, 
such as polyamines, inorganic phospha:e ions and 
ADP, enhance the uniporter's al~nity for Ca 2÷ suffi. 
ciently tbr significant Ca a+ uptake to occur under basal 
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Fi~. 2. Time-course ofthe MIBG.stimulated increase in the content 
of the mitoehondrial Ca:÷ pool. Isolated hepatoeytes were incubated 
in the absence (o) or presence ( l of MIBG (lO0/aM), and the size of 
the rnitochondrial Ca"" pool was measured at the indicated time points 
as described in section 2.Each point represents the mean : S.E. offour 
to seven independent experiments. 
[Ca-~]~ conditions [22,23]. In the absence of MIBG to 
prevent ADP-ribosylation reactions~ the Ca'~'/H * an- 
tiporter is likely to be constitutively active in order to 
keep the in situ mitochondrial Ca 2+ content low [24]. 
The cycling of Ca 2~ by mitochondria was further in- 
vestigated by (i) pharmacologically altering the cy- 
tosolic Ca:" buffering capacity and (it) raising [Ca2+]~. 
The cytosolic Ca ~-* buffering capacity was increased by 
loading the hepatocytes with the Ca 2. chelator flue 3 
[18]. This treatment abolished the ability of MIBG to 
Table 1 
Effect of tlluHQ on the increase in the mitoehondrial Ca"" pool in 
isolated hepatocytes induced by MIBG 
Treatment Mitochondrial Non-mitochondrial 
Ca -~* pool Ca :* pool 
(nmol Ca"~/10 ° cells) (nmol Ca:+/10 ~ cells) 
Control* 0.25 + 0.05 0,62 ± 0,08 
100/~M MIBG 0.55 ± 0.14 0.66 ± 0.16 
10/~M tBuHQ 0.83 ± 0.31 1.09 ±0.17 
1o9/aM MIBG ~- 1.97 ± 0.47** 0.53 ± 0.10 
10/aM tBuHQ 
Isolated hepatocytez were treated with MIBG (100/tM) or tBuHQ (I 0 
/~M) or a combination f both compounds for 20 rain before measur- 
ing the Ca -~. content of the mitochondrial and aon.mitoehondrial 
pools as described in section 2. Each value is the mean ± S.E. of five 
separate experiments e.~cept for the 10-~M tBuHQ treatment which 
is lhe mearl + SE for four experiments. 
*Controls contained 0.1% dimethyl sulfoxide. 
**Statistically different from other treatment 8reaps (P < 0.05). 
stimulate an increase in the size of the mitochondrial 
Ca "-+ pool (data not shown). In contrasts treatment of 
the hepatocytes with tBuHQ (which mobilizes the endo- 
plasmic reticular Ca 2' store [19] and stimulates capaci- 
tative Ca 2. entry across the plasma membrane [20] 
thereby raising [Ca'~']~ to a level similar to that produced 
by a Ca2+-mobilizing hormone) stimulated a very large 
increase in the size of the mitochondrial Ca 2. store in 
the presence of MIBG {Table 1). Although elevating 
[Ca"+]~ with tBuHQ was by itself sufficient o raise the 
mitochondrial Ca 2+ content, the combination of  MIBG 
and tBuHQ produced a synergistic response. The treat- 
ment with tBuHQ also elevated the non-mit~chondrial 
ionophore-releasable pool; this was most likely due to 
the net accumulation of Ca ~-~ in the cell following the 
sustained activation of capacitative Ca "~+ influx across 
the plasma membrane [20]. The treatment of hepato- 
cytes with MIBG alone did not produce any change in 
[Ca~'+]~ and did not increase Ca -~ influx across the 
plasma membrane (data not shown). Taken together, 
these results show that mitochondria in sita continu- 
ously take up and release Ca'-* and that the degree of 
Ca -~ cycling by the mitochondria is dictated by the 
availability of Ca :+ from the cytosol. 
We have recently reported [15] that the immunosup- 
pressant cyclosporin A stimulates a similar sequestra- 
tion of  Ca -~* mitochondria in hepatoeytes. Like MIBG, 
cyelosporin A also prevents the prooxidant-induced 
Ca ~'+ release from mitoehondria [25]. However, the ira. 
munosuppressant has been shown to inhibit the proox- 
idant-induced pyridine nucleotide hydrolysis [9,10] and 
is therefore believed to act prior to the step regulated by 
MIBG is actively accumulated by cells and is pre- 
dominantly concentrated in the mitochondria [26]. 
MIBG can also function as a complex I inhibitor of the 
mitochondrial respiratory chain and thi~ is probably the 
mechanism which accounts for the cytotoxicity ob- 
served with high concentrations of the inhibitor [21]. 
Hence, MIBG is very similar in a number of  aspects to 
l-methyl-4-phenyipyridine (MPP*), the active metabo- 
lite of the neurotoxin l-methyl-4-phenyl-l,2,3,6- 
tetrahydropyridine (MPTP). Both compounds are ac- 
tively accumulated in mitochondria [27,28] and have 
been shown to inhibit mitochondrial respiration at the 
level of site 1 [28°29]. However~ in clear contrast with 
MIBG, MPP* produced a rapid discharge ofmitochon- 
drial Ca -~* in hepatocytes [30], demonstrating that the 
increase it, the mitochondrial Ca 2+ pool by MIBG was 
not linked to the action of MIBG as an inhibitor of  
NADH dehydrogenase or its ability to be accumulated 
by mitochondria. 
In conclusion, this study has shown that the inhibitor 
of protein mono ADP..ribosylation, MIBG, stimulates 
fl~e selective accumulation of Ca :+ by mitoehondria in 
intact hepatocytes, probably by affecting the Ca ~'~ efflux 
pathway. Our results therelbre suggest that the activity 
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of  the inner mitochondrial  membrane Ca"+/H ~" an- 
tiporter and thereby mitochond:'ial Ca"" homeostasis i
controlled by protein ADP.ribosylation, 
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